Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of duchenne muscular dystrophy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Muscle and Nerve

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mus.21743PMID 20730876PMCID PMC4505731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice

  2010cited by this paper
• Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.

  2009cited by this paper
• A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.

  2009cited by this paper
• Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.

  2009cited by this paper
• Redundancy of myostatin and growth/differentiation factor 11 function

  2009cited by this paper
• Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice

  2008cited by this paper
• Myostatin blockade improves function but not histopathology in a murine model of limb‐girdle muscular dystrophy 2C

  2008cited by this paper
• Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.

  2008cited by this paper
• A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy

  2008cited by this paper
• Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators.

  2008influential reference
• Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

  2008cited by this paper
• Cell Communication and Signaling BioMed Central Review

  2008cited by this paper
• Myostatin does not regulate cardiac hypertrophy or fibrosis.

  2007cited by this paper
• Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways

  2007cited by this paper
• FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults

  2007cited by this paper
• Muscle growth after postdevelopmental myostatin gene knockout.

  2007cited by this paper
• Lack of myostatin results in excessive muscle growth but impaired force generation

  2007influential reference
• TGFβ–SMAD signal transduction: molecular specificity and functional flexibility

  2007cited by this paper
• Genetic interactions between activin type IIB receptor and Smad2 genes in asymmetrical patterning of the thoracic organs and the development of pancreas islets

  2007cited by this paper
• Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse.

  2007cited by this paper
• Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice.

  2006cited by this paper
• Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition.

  2006cited by this paper
• Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle.

  2006cited by this paper
• Contractile properties of EDL and soleus muscles of myostatin-deficient mice.

  2006cited by this paper
• Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy.

  2006cited by this paper
• Regulation of muscle growth by multiple ligands signaling through activin type II receptors.

  2005influential reference
• Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ.

  2005cited by this paper
• Improved Success of Myoblast Transplantation in mdx Mice by Blocking the Myostatin Signal

  2005cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases Elimination of Myostatin Does Not Combat Muscular Dystrophy in dy Mice but Increases Postnatal Lethality

  2005cited by this paper
• The transforming growth factor-beta superfamily of receptors.

  2004cited by this paper
• Respiratory muscle fibres: specialisation and plasticity

  2004cited by this paper
• ROLE OF CONTRACTION‐INDUCED INJURY IN THE MECHANISMS OF MUSCLE DAMAGE IN MUSCULAR DYSTROPHY

  2004cited by this paper
• Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B

  2004cited by this paper
• Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.

  2004cited by this paper
• Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.

  2003cited by this paper
• Myostatin-deficient mice lose more skeletal muscle mass than wild-type controls during hindlimb suspension.

  2003cited by this paper
• Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains.

  2003cited by this paper
• Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases

  2003cited by this paper
• Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

  2002cited by this paper
• Functional improvement of dystrophic muscle by myostatin blockade

  2002cited by this paper
• Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

  2002cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• Regulation of myostatin activity and muscle growth

  2001cited by this paper
• Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver.

  2001cited by this paper
• Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle

  2001cited by this paper
• Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-β Family*

  2000cited by this paper
• How cells read TGF-beta signals.

  2000cited by this paper
• Dominant negative myostatin produces hypertrophy without hyperplasia in muscle

  2000cited by this paper
• Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family.

  2000cited by this paper
• Cloning of zebrafish activin type IIB receptor (ActRIIB) cDNA and mRNA expression of ActRIIB in embryos and adult tissues.

  1999cited by this paper
• Dioxinlike components in incinerator fly ash: a comparison between chemical analysis data and results from a cell culture bioassay.

  1997cited by this paper
• The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse.

  1997cited by this paper
• Prognostic implications of qualitative assessment of left ventricular function compared to simple routine quantitative echocardiography.

  1997cited by this paper
• mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos.

  1995influential reference
• Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins.

  1994cited by this paper
• Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors.

  1992cited by this paper
• Expression cloning of an activin receptor, a predicted transmembrane serine kinase.

  1991cited by this paper
• The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

  1991cited by this paper
• The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs

  1988cited by this paper
• Transforming Growth Factor (cid:1) and Activin Tonically Inhibit DNA Synthesis in the Rat Liver

  year unknowncited by this paper
• The FASEB Journal • Research Communication Myostatin propeptide-mediated amelioration of dystrophic pathophysiology

  year unknowninfluential reference

• CRISPR/Cas9-Targeted Myostatin Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice

  2025cites this paper
• Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy

  2025cites this paper
• Poor bone health in Duchenne muscular dystrophy: a multifactorial problem beyond corticosteroids and loss of ambulation

  2024cites this paper
• Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs

  2021cites this paper
• Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success

  2021influential citation
• Muscle Atrophy

  2020cites this paper
• The elusive promise of myostatin inhibition for muscular dystrophy

  2020cites this paper
• Mathematical Model of Muscle Wasting in Cancer Cachexia

  2020cites this paper
• Iron Metabolism of the Skeletal Muscle and Neurodegeneration

  2019cites this paper
• Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice

  2019cites this paper
• Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle.

  2019cites this paper
• A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice

  2019cites this paper
• Skeletal muscle fibrosis: an overview

  2018cites this paper
• Le métabolisme lipidique dans les altérations mitochondriales induites par l'absence de myostatine: Impact de l' entrainement en endurance

  2018cites this paper
• Exercise training in chronic kidney disease : an exploration of the effects on skeletal muscle mass, function, and the molecular responses

  2018cites this paper
• Past, Present, and Future Perspective of Targeting Myostatin and Related Signaling Pathways to Counteract Muscle Atrophy.

  2018cites this paper
• Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone

  2018cites this paper
• Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial

  2017cites this paper
• Prevention of chemotherapy‐induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

  2017cites this paper
• Supraphysiological levels of GDF11 induce striated muscle atrophy

  2017influential citation
• Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies

  2017cites this paper
• Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

  2017cites this paper
• ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass

  2017cites this paper
• A WFIKKN fehérjék szerepe a miosztatin aktivitás szabályozásában

  2017cites this paper
• New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration

  2016cites this paper
• Growth Factors and Cytokines in Skeletal Muscle Development, Growth, Regeneration and Disease

  2016cites this paper
• Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy

  2016cites this paper
• The TGF-β Signalling Network in Muscle Development, Adaptation and Disease.

  2016cites this paper
• ActRIIB blockade increases force‐generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo

  2016cites this paper
• The function of Activin receptor type IIb signaling in adult skeletal muscle

  2016cites this paper
• Effects of muscular dystrophy, exercise and blocking activin receptor IIB ligands on the unfolded protein response and oxidative stress.

  2016cites this paper
• Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy

  2015cites this paper
• Circulating Biomarkers for Duchenne Muscular Dystrophy

  2015cites this paper
• Pharmacology of manipulating lean body mass

  2015cites this paper
• Prospect for Pharmacological Therapies to Treat Skeletal Muscle Dysfunction

  2015cites this paper
• Genetic disruption of Smad7 impairs skeletal muscle growth and regeneration

  2015cites this paper
• Therapeutic potential of orphan drugs for the rare skeletal muscle diseases

  2015cites this paper
• Evaluation of Electrical Impedance as a Biomarker of Myostatin Inhibition in Wild Type and Muscular Dystrophy Mice

  2015cites this paper
• Individual and combinatory effects of voluntary wheel running and sActRIIB-Fc administration on redox-balance in mdx mice

  2015influential citation
• Evaluating the PGC-1 alpha pathway and a new preclinical model to advance treatment options for dystrophinopathies

  2014cites this paper
• Discovery of biological networks using an optimized partial correlation coefficient with information theory algorithm on Stampede's Xeon and Xeon Phi processors

  2014cites this paper
• Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy.

  2014cites this paper
• Myostatin naturally inhibits skeletal muscle growth by binding to ActRIIB, a receptor on the cell surface of myofibers. Because blocking myostatin in an adult wild-type mouse induces profound muscle hypertrophy, we applied a soluble ActRIIB receptor to models

  2014cites this paper
• Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition

  2014cites this paper
• Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle.

  2014cites this paper
• Myostatin is a key mediator between energy metabolism and 1 endurance capacity of skeletal muscle 2

  2014cites this paper
• Myostatin and related proteins on the control of skeletal muscle mass and capillary density

  2013cites this paper
• Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling.

  2013cites this paper
• Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse.

  2013cites this paper
• Molecular basis of muscle hypertrophy and atrophy: Potential therapy for muscular dystrophy

  2013cites this paper
• myostatin and activins signaling, and capillary density are altered by blocking of Muscle protein synthesis, mTORC1/MAPK/Hippo

  2013cites this paper
• Myostatin/activin pathway antagonism: molecular basis and therapeutic potential.

  2013cites this paper
• Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins.

  2013cites this paper
• Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy

  2013cites this paper
• Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.

  2013cites this paper
• Cytokines and Chemokines as Regulators of Skeletal Muscle Inflammation: Presenting the Case of Duchenne Muscular Dystrophy

  2013cites this paper
• Structural and functional characterizations of activin type 2B receptor (acvr2b) ortholog from the marine fish, gilthead sea bream, Sparus aurata: evidence for gene duplication of acvr2b in fish.

  2012cites this paper
• A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice

  2012cites this paper
• Psychosocial Support Needs of Families of Boys with Duchenne Muscular Dystrophy

  2012cites this paper
• Structural and functional chara cterizations of activin type 2 B receptor ( acvr 2 b ) ortholog from the marine fish , gilthead sea bream , Sparus aurata : evidence for gene duplication of acvr 2 b in fish

  2012cites this paper
• TGF-β signaling in Duchenne muscular dystrophy

  2012cites this paper
• Cell–matrix interactions in muscle disease

  2012cites this paper
• Administration of a Soluble Activin Type IIB Receptor Promotes the Transplantation of Human Myoblasts in Dystrophic Mice

  2012cites this paper
• Interference with myostatin/ActRIIB signaling as a therapeutic strategy for Duchenne muscular dystrophy.

  2012cites this paper
• Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse

  2012cites this paper
• Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice

  2012cites this paper
• Current pharmacologic management in selected neuromuscular diseases.

  2012cites this paper
• Combined Effect of AAV-U7-Induced Dystrophin Exon Skipping and Soluble Activin Type IIB Receptor in mdx Mice

  2012cites this paper
• A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice.

  2012cites this paper
• Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

  2011cites this paper
• Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice

  2011cites this paper
• Role of TGF-β signaling in inherited and acquired myopathies

  2011influential citation
• Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle.

  2011cites this paper
• Long-Term Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Golden Retriever Muscular Dystrophy

  2011influential citation
• Gene expression profiling of skeletal muscles treated with a soluble activin type IIB receptor.

  2011cites this paper